Effects of increasing sensitizing doses of ovalbumin on airway hyperresponsiveness in asthmatic mice
Immunity, Inflammation and Disease · 2024-03 · 12 (3)
DOI: 10.1002/iid3.1225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 27.03.2024. Verfasst von Yan-Jiao Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Shanghai Research Institute of Acupuncture and Meridian, Yueyang Hospital of Integrated Traditional Chinese and West…. Hauptthemen laut MEDLINE: Bronchial Hyperreactivity, Asthma, Respiratory Hypersensitivity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Shanghai Sailing Program.
Abstract (Originalsprache)
Background
The dosage of ovalbumin (OVA) during the sensitization stage is considered a crucial factor in the development of airway hyperresponsiveness (AHR). However, the inconsistent dosages of sensitizing OVA used in current studies and the lack of research on their impact on AHR are notable limitations.
Methods
We examined the impact of increasing sensitizing doses of OVA in a murine asthma model, which entailed initial sensitization with OVA followed by repeated exposure to OVA aerosols. BALB/c mice were primed with doses of OVA (0, 10, 20, 50, and 100 μg) plus 1 mg Alum on Days 0 and 7, and were challenged with OVA aerosols (10 mg/mL for 30 min) between Days 14 and 17. Antigen‐induced AHR to methacholine (MCh), as well as histological changes, eosinophilic infiltration, and epithelial injury were assessed.
Results
The result indicated that there are striking OVA dose‐related differences in antigen‐induced AHR to MCh. The most intense antigen‐induced AHR to MCh was observed with sensitization at 50 μg, while weaker responses were seen at 10, 20, and 100 μg. Meanwhile, there was a significant increase in eosinophil count with sensitization at 50 μg. The changes of AHR were correlated with total cells count, lymphocytes count, eosinophils count, and basophils count in bronchoalveolar lavage fluid; however, it did not correlate with histological changes such as cellular infiltration into bronchovascular bundles and goblet cell hyperplasia of the bronchial epithelium.
Conclusion
Overall, this study demonstrated that sensitization with 50 μg of OVA resulted in the most significant AHR compared to other dosages. These findings may offer valuable insights for future research on mouse asthma modeling protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, Shanghai Research Institute of Acupuncture and Meridian, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, P.R. China.
- Deparment of Acupuncture and Moxibustion, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
- Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
ORCID-Profile: Yong-Qing Yang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Shanghai Sailing Program
- Shanghai Municipal Commission of Health and Family Planning
Zitieren
APA
Chen, Y. J., Yuan, Y., Peng, L., Dong, X. Y., Xu, Y. D., Wang, Y., & Yang, Y. Q. (2024). Effects of increasing sensitizing doses of ovalbumin on airway hyperresponsiveness in asthmatic mice. Immunity, Inflammation and Disease, 12(3). https://doi.org/10.1002/iid3.1225
Vancouver
Chen YJ, Yuan Y, Peng L, Dong XY, Xu YD, Wang Y, et al. Effects of increasing sensitizing doses of ovalbumin on airway hyperresponsiveness in asthmatic mice. Immunity, Inflammation and Disease. 2024;12(3). doi:10.1002/iid3.1225
BibTeX
@article{Chen2024,
author = {Chen, Yan-Jiao and Yuan, Yu and Peng, Lu and Dong, Xin-Yi and Xu, Yu-Dong and Wang, Yu and Yang, Yong-Qing},
title = {Effects of increasing sensitizing doses of ovalbumin on airway hyperresponsiveness in asthmatic mice},
journal = {Immunity, Inflammation and Disease},
year = {2024},
volume = {12},
number = {3},
doi = {10.1002/iid3.1225}
}
EUVIMED